Tweenvest Stocks

BiomX Inc. (NYSEAM: HLSQ)

Health Care · Biotechnology · US

$0.71

-44.41% today · -99.3% 1Y

BiomX Inc. (NYSEAM: HLSQ) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.89M and employs 20 people.

Over the last twelve months the share price has lost 99.3%, trading between 0.64 and 122.93.

Tweenvest scores BiomX Inc. across four factors: quality 29/100, value 61/100. Its strongest factor is value.

HLSQ price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$1.89M
Revenue (TTM)
$332.00K
P/E
EPS
-109.54
Dividend yield
Beta (5Y)
1.34
52-week high
$122.93
52-week low
$0.64
Avg volume (3M)
Shares outstanding
2.67M
Employees
20
Next earnings

About BiomX Inc.

Operating as a holding company, BiomX Inc. is dedicated to advancing technologies within the realms of defense, security, and essential infrastructure. Its diverse array of offerings features specialized solutions like counter-unmanned aerial vehicle systems, intelligent AI-powered command-and-control, comprehensive border and perimeter protection, expansive surveillance capabilities, and aerial fire suppression tools. The firm caters to a broad spectrum of clients, encompassing national defense organizations, primary government contractors, transportation management entities, local municipalities, and key infrastructure operators. BiomX Inc. commenced operations in 2015 and maintains its principal office in Dover, Delaware.

ISIN
US09090D5095
Founded
2015
Listed since
Mar 13, 2019
Exchange
NYSE American LLC
Currency
USD
CompanyMarket capPriceDay
Anatara Lifesciences LtdASX: ANR$2.02MAU$0.01-10.00%
Oncology Pharma Inc.OTCPK: ONPH$2.01M$0.05+1.36%
BPH Global LtdASX: BP8$2.01MAU$0.01+9.09%
Cynata Therapeutics LimitedASX: CYP$1.90MAU$0.01-8.33%
Valion Bio, Inc.NasdaqCM: VBIO$1.88M$2.12-6.19%
Shuttle Pharmaceuticals Holdings, Inc.NasdaqCM: SHPH$1.88M$3.21-9.07%
Decoy Therapeutics Inc.NasdaqCM: DCOY$1.82M$2.78+4.12%
BioXcel Therapeutics, Inc.OTCPK: BTAI.Q$1.82M$0.06-22.77%

Browse every Biotechnology company →

Figures last refreshed Sep 20, 2026.